- Home
- CARV vs COCP Comparison
CARV vs COCP Comparison
Compare CARV & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARV
- COCP
- Stock Information
- Founded
- CARV 1948
- COCP 2006
- Country
- CARV United States
- COCP United States
- Employees
- CARV N/A
- COCP N/A
- Industry
- CARV Savings Institutions
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- CARV Finance
- COCP Health Care
- Exchange
- CARV Nasdaq
- COCP Nasdaq
- Market Cap
- CARV 13.2M
- COCP 15.4M
- IPO Year
- CARV 1994
- COCP N/A
- Fundamental
- Price
- CARV $2.35
- COCP $1.22
- Analyst Decision
- CARV
- COCP Strong Buy
- Analyst Count
- CARV 0
- COCP 1
- Target Price
- CARV N/A
- COCP $6.00
- AVG Volume (30 Days)
- CARV 255.3K
- COCP 4.4M
- Earning Date
- CARV 11-13-2025
- COCP 11-12-2025
- Dividend Yield
- CARV N/A
- COCP N/A
- EPS Growth
- CARV N/A
- COCP N/A
- EPS
- CARV N/A
- COCP N/A
- Revenue
- CARV $22,032,000.00
- COCP N/A
- Revenue This Year
- CARV N/A
- COCP N/A
- Revenue Next Year
- CARV N/A
- COCP N/A
- P/E Ratio
- CARV N/A
- COCP N/A
- Revenue Growth
- CARV N/A
- COCP N/A
- 52 Week Low
- CARV $1.30
- COCP $1.12
- 52 Week High
- CARV $3.85
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- CARV 53.46
- COCP 30.69
- Support Level
- CARV $2.20
- COCP $1.37
- Resistance Level
- CARV $3.85
- COCP $2.67
- Average True Range (ATR)
- CARV 0.42
- COCP 0.17
- MACD
- CARV -0.01
- COCP -0.02
- Stochastic Oscillator
- CARV 30.88
- COCP 2.99
About CARV Carver Bancorp Inc.
Carver Bancorp Inc is a holding company and conducts its business as a unitary saving and loan holding firm and the business of the company consists of the operation of its subsidiary. The bank offers a wide range of financial solutions to meet customers' banking. It offers other consumer and commercial banking products and services, such as debit cards, online banking, online bill pay, and telephone banking. The company provides deposit products, such as demand, savings, and time deposits for consumers, businesses, and governmental and quasi-governmental agencies in its market area within New York City.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).